Delivery Order SPE2DB20D3103-SPE2DB26FL4S1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Erleada 240 mg tablets (30-unit packages) valued at $14,704.98. This competitively awarded, firm fixed-price contract carries an ultimate completion date of October 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) with a firm fixed price structure. The delivery order is set to be completed by September 16, 2025, and represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed-price contract, with an ultimate completion date of October 20, 2025, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was competitively made with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.79 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) on October 29, 2025, with completion scheduled for November 20, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in quantities of 120 units. This non-competitive delivery order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, represents a firm fixed price transaction utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,352.49 and employs firm fixed pricing. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Erleada 60 mg tablets (120-count units) under a firm fixed price contract valued at $15,117.58. This is a non-set-aside competitive award with an ultimate completion date of October 16, 2025, and the product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ERLEADA 60 mg tablets (120 count) valued at $7,965.80 under a firm fixed price contract type. The award was made on October 20, 2025, with an ultimate completion date of November 10, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4S1Delivery Order
The Defense Logistics Agency awarded a $7,352.49 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of Erleada 240 mg tablets, with a completion date of November 24, 2025. This non-set-aside, firm fixed-price contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate operations as a major pharmaceutical distributor serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a wide range of pharmaceuticals, medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive portfolio of federal awards demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 10/31/25 |